Business Wire

Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms

OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active ...
Business Wire

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

The Dayspring system includes a low-profile active garment made of soft, breathable mesh using Koya’s proprietary Flexframe TM technology; a smart, rechargeable, hand-held controller that can be worn ...
Fox 5 San Diego

Koya Medical Presents Two Newly Published Clinical Studies for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease at the AVLS 2022 Annual Congress

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
Yahoo Finance

Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease

OAKLAND, Calif., October 04, 2022--(BUSINESS WIRE)--Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
The Globe and Mail

Koya Medical Receives FDA Clearance for Dayspring Lite, Bringing Much-Needed Movement to People Beginning Compression Therapy to Treat Lymphedema and Venous Disease

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, received Food and Drug Administration (FDA ...
Yahoo Finance

Koya’s NPCD device proves more effective than APCDs in lymphedema

Koya Medical has shared data highlighting that its non-pneumatic compression device (NPCD) demonstrated better efficacy and improved quality of life in patients with lower extremity lymphedema. The ...
WDTN

Koya Medical Announces Topline Results from Its Latest Trial on the Treatment of Lower Extremity Lymphedema at VENOUS2024

OAKLAND, Calif. and TAMPA, Fla., March 6, 2024 /PRNewswire/ -- Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized ...
Stockhouse

Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities

OAKLAND, Calif. , May 26, 2021 /PRNewswire/ -- Koya Medical , a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that it has ...
Business Insider

Koya Medical to Present at Oppenheimer MedTech, Tools & Diagnostics Summit

OAKLAND, Calif., May 20, 2021 /PRNewswire/ -- Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, will present at the Oppenheimer ...
Mena FN

Koya Medical Presents Two Newly Published Clinical Studies For Dayspring® Active Compression Treatments For Lymphedema And Venous Disease At The AVLS 2022 Annual Congress'

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...